Archived App
This is an archived listing of the app previously available on the App Store.
This platform facilitates clinical trials by bringing them directly to users' mobile devices. It streamlines recruitment, screening, and data collection, offering a cost-effective and efficient alternative to traditional on-site studies. Users can participate in trials, receive compensation, and contribute to research from their own homes.
2.14
August 29, 2020
- Bug fixes - Performance improvements - UI fixes
MoreClaimIt 2018 brings clinical trials to your mobile device, handling recruitment, screening, informed consent, and data collection online. This approach aims to reduce costs and speed up trial completion compared to traditional methods.
Participants can join trials from home, receive financial compensation through milestone payments via PayPal, and contribute to medical research conveniently. The app also allows for integration with health devices for automatic data collection.
Subjects link a PayPal account to the ClaimIt app to receive compensation for their participation. Payments are structured as milestone payments, designed to incentivize the completion of the trial.
Yes, the ClaimIt app can link to various health devices like Apple Watch, Fitbit, activity trackers, Bluetooth scales, and blood pressure monitors for automatic data collection.
Data collection includes completing questionnaires and eCRFs, capturing product compliance through photos, and potentially attending lab visits or online appointments. The app also supports integration with other mHealth apps.
ClaimIt 2018 is available for iPhone, iPad, and iPod, indicating compatibility with Apple's iOS ecosystem.
The latest version of ClaimIt 2018 is 2.14, and it was last updated on August 29, 2020. This suggests a development cycle that may vary in frequency.
ClaimIt 2018 has an age rating of 17+, meaning it is intended for mature audiences due to the nature of clinical trial participation and data handling.
Promoted
3 month for FREE
PROMO CODE: "appshunter"
(17)
